⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASST News
Strive, Inc. Class A Common Stock
Asieris' CEVIRA® Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
prnewswire.com
ASST
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
prnewswire.com
ASST
Strive Announces Closing of Upsized & Oversubscribed Follow-On Offering of SATA Stock and Concurrent Exchange of Semler Notes
globenewswire.com
ASST
SATA
COIN
Orthogonal Thinker Inc. Announces Final Phase of Consolidation of EI Ventures and Subsidiaries and Progress Toward Regulated Security Token Evaluation Ready to Announce with Confidence?
newsfilecorp.com
ASST
BNC
Strive Announces the Completion of Semler Scientific Acquisition
globenewswire.com
ASST
SMLR
Strive, Inc. (Nasdaq: ASST) and Semler Scientific (Nasdaq: SMLR) Announce Shareholder Approval for Acquisition of Semler Scientific
globenewswire.com
ASST
SMLR
Strive Increases SATA Perpetual Preferred Stock Dividend to 12.25%
globenewswire.com
ASST
SATA
SMCI
Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR
prnewswire.com
SMLR
ASST
Strive Announces $500,000,000 SATA At-The-Market Program
globenewswire.com
ASST
SMCI
Strive, Inc. Announces Third Quarter 2025 Financial Results
globenewswire.com
ASST